Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze AVTX stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate AVTX investment potential.

What is AVTX stock price today?

Get real-time AVTX stock price, historical data, and price charts on Financhill. Track AVTX performance with our advanced analysis tools.

Is AVTX a good investment?

Evaluate AVTX investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy AVTX stock?

To buy AVTX stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of AVTX?

View detailed market capitalization data and company valuation metrics for AVTX on our comprehensive analysis page.

What is the P/E ratio of AVTX?

Use our fundamental analysis tools to view AVTX P/E ratio and compare valuation metrics with industry peers.

What are AVTX earnings?

View AVTX earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Avalo Therapeutics, Inc. Stock Predictions

Still Time to Get In: RAD Intel at $0.85/Share

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Buy

AVTX
Avalo Therapeutics, Inc.

Last Price:

$17.92

Seasonality Move:

9.29%

7 Day Trial

ALL ACCESS PASS

$ 7

Missed $0.81? RAD Intel Now Open at $0.85/Share

Avalo Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Avalo Therapeutics, Inc. has on average historically fallen by 0.9% based on the past 9 years of stock performance.
Avalo Therapeutics, Inc. has fallen lower in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Is Avalo Therapeutics, Inc. Stock Undervalued?

The current Avalo Therapeutics, Inc. [AVTX] share price is $17.95. The Score for AVTX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
AVTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Avalo Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Avalo Therapeutics, Inc. has on average historically fallen by 0.9% based on the past 9 years of stock performance.

Avalo Therapeutics, Inc. Stock Rating

Buy

Avalo Therapeutics, Inc. (AVTX) is a Buy

Is Avalo Therapeutics, Inc. overpriced?

Avalo Therapeutics, Inc. has fallen lower in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Avalo Therapeutics, Inc. Stock Price History

Is AVTX stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AVTX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

avalotx.com

52-Week Data

52-Week High:

19.41

52-Week Low:

3.39

Prediction Charts

Market Cap:

325.5M

Price in USD:

17.95

Volume:

381.1K

Beta:

1.29

Technical Analysis

SMA50:

15.82

SMA100:

12.45

SMA200:

8.98

52-Wk Change:

79.5%

Stock Predictions

Is Avalo Therapeutics, Inc. stock public?

Yes, Avalo Therapeutics, Inc. is a publicly traded company.
What is the Avalo Therapeutics, Inc. stock quote today?

The Avalo Therapeutics, Inc. stock price is 17.95 USD today.
How to buy Avalo Therapeutics, Inc. stock online?

You can buy Avalo Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-14	14.30	15.11	15.61	14.01
Nov-17	15.11	16.88	17.54	14.97
Nov-18	16.76	18.00	18.52	16.09
Nov-19	18.01	17.59	18.18	17.29
Nov-20	17.95	17.74	18.15	16.75
Nov-21	17.99	17.83	18.07	16.90
Nov-24	17.91	18.00	18.90	17.55
Nov-25	18.11	18.99	19.29	18.00
Nov-26	19.12	18.55	19.13	18.39
Nov-28	18.60	19.00	19.25	18.33
Dec-1	18.61	16.78	18.75	16.09
Dec-2	16.97	15.87	16.97	15.54
Dec-3	15.97	16.97	16.97	15.53
Dec-4	16.91	17.95	18.80	16.63

Avalo Therapeutics, Inc. Earnings

Avalo Therapeutics, Inc. Earnings Report: Per Share Avalo Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Avalo Therapeutics, Inc. Forecast Revenue Growth

Avalo Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Avalo Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $19.72 per share, and an increase next year of $2.02 per share.

* Avalo Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.